Package 71209-012-03

{"route": ["ORAL"], "spl_id": "862f0b42-695e-4170-983d-cfb848967cf3", "openfda": {"upc": ["0371209012034", "0371209014038", "0371209013031"], "unii": ["9IY2357JPE"], "rxcui": ["312835", "312836", "314214", "314215"], "spl_set_id": ["e7e641fe-39bd-4681-a430-6dedeb6d6af5"], "manufacturer_name": ["Cadila Pharmaceuticals Limited"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "60 CAPSULE in 1 BOTTLE (71209-012-03)", "package_ndc": "71209-012-03", "marketing_start_date": "20140211"}, {"sample": false, "description": "500 CAPSULE in 1 BOTTLE (71209-012-10)", "package_ndc": "71209-012-10", "marketing_start_date": "20140211"}], "brand_name": "Rivastigmine Tartrate", "product_id": "71209-012_862f0b42-695e-4170-983d-cfb848967cf3", "dosage_form": "CAPSULE", "pharm_class": ["Cholinesterase Inhibitor [EPC]", "Cholinesterase Inhibitors [MoA]"], "product_ndc": "71209-012", "generic_name": "Rivastigmine Tartrate", "labeler_name": "Cadila Pharmaceuticals Limited", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Rivastigmine Tartrate", "active_ingredients": [{"name": "RIVASTIGMINE TARTRATE", "strength": "1.5 mg/1"}], "application_number": "ANDA203844", "marketing_category": "ANDA", "marketing_start_date": "20140211", "listing_expiration_date": "20261231"}